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Most published studies about Cystic Fibrosis (CF) are European or North American. There are still few publications about the
characteristics of ﬁbrocystic populations in developing countries. The incidence of cystic ﬁbrosis (CF) in Brazil varies among
diﬀerent regions (1:10,000 in Minas Gerais, 1:9,500 in Paran´ a, 1:8,700 in Santa Catarina, and 1:1600 in Rio Grande do Sul).
The prevalence of the DF508 mutation also varies according to population: 33% in Sao Paulo, 49% in Rio Grande do Sul, 27%
in Santa Catarina, and 52% in Minas Gerais. Cough and nasal obstruction are the most common symptoms. The variation in
nasal polyposis prevalence may be explained by population genotypic characteristics in a country that spans a continent. Findings
on nasal endoscopy and computed tomography (CT) have better correlation than do this information compared with surgical
and clinical history. Microbiologic studies suggest a high level of early contamination of the airways. Sensorineural hearing loss
(SNHL) occurs in these patients as a result of ototoxic antibiotics. The data compiled in this paper is useful, but also lead to the
general agreement that more research would be welcome due to the unique characteristics of this country.
1.Introduction
Cysticﬁbrosis(CF)isthemostcommoninheritedautosomal
recessive disease among Caucasians [1–6]. It has a frequency
of 1:2.000 to 1:6.000 in the Caucasian population of
developed countries [1, 3, 4, 6–9], being rare in populations
with African (1:30.000) and Asian (1:90.000) origins [10,
11]. In Brazil, the incidence is 1:9.500 in Paran´ a[ 12]a n d
1:8.700 in Santa Catarina [13] and 1:10.000 in Minas
Gerais [14]. The disease is caused by mutations in the gene
encodingthecysticﬁbrosistransmembraneregulatorprotein
(CFTR), mapped in the human chromosome at 7q31. This
gene, described in 1989 [15–17], encodes a protein that
acts as a chloride channel, and its dysfunction results in
an abnormal transport of sodium and chloride through the
apical membrane of epithelial cells of the upperaerodigestive
tract and exocrine glands. Abnormal ﬂow of salt and water
leads to dehydration of ﬂuids of the exocrine glands and a
change in the viscoelastic properties of mucins [5, 6, 18, 19].
Changing the composition and viscosity of mucus leads
to dysfunctional mucociliary clearance and to obstruction of
the paranasal sinus ostia, predisposing to local inﬂammation
with consequent hypoxia and increased partial pressure
of carbon dioxide. This results in mucosal edema and
greater compromising of ciliary function and favors bacterial
colonization and infection, particularly by Staphylococcus
aureus and Pseudomonas aeruginosa [3, 6, 18–20]. Nasal
polyposis in CF patients was described for the ﬁrst time in
1959 [21]. Its frequency varies in diﬀerent populations and
depends on the evaluative technique. A compromised nasal
sinus is believed to aggravate the pulmonary picture [20],
and thus the participation of otolaryngologists to address
this particular group of patients becomes very important.2 International Journal of Otolaryngology
Another important issue for the otolaryngologists in mon-
itoring CF patients is their hearing. In spite of the low
prevalence of middle ear disease in these patients, there is in
fact sensorineural hearing loss caused by ototoxic drugs.
Most articles on this subject are European or American,
involving both children and adults with CF. There are still
few publications about the characteristics of ﬁbrocystic pop-
ulations in developing countries and, in general, with small
samples. In Brazil since 1972 when the ﬁrst speciﬁc CF
center was opened in Rio de Janeiro many centers have been
developed. During the last decades more than 13 centers
were created ﬁrst in the southwest and south. Today more CF
clinics are being recognized all over the country. As a result
more national literature has been available, but there is still a
needtobettercharacterizeCFpatientswithregardtorhinos-
inusitis. There is great genetic heterogeneity as well as a wide
rangeofmutationswithlargevarietyofclinicalpresentations
observed, which may be explained by particular phenotypic
characteristics in the Brazilian population and even popula-
tionsofeachregioninthecountry,sinceBrazilhascontinen-
tal dimensions and represents a unique patient population
given its European and American ancestry (Table 1).
The purpose of this study is to gather data from the main
Brazilian publications on otorhinolaryngological manifesta-
tions of CF patients and to compare with studies from other
countries.
2.Symptomatology
In a Brazilian study involving 100 children and adolescents
with CF in the state of Minas Gerais, the most commonly
reported symptoms in addition to cough (45%) were oral
breathing (44%), restless sleep (42%), nasal obstruction
(37%), halitosis (33%), headache (30%), and rhinorrhea
(29%). Only two patients complained of anosmia and about
10% complained of periorbital or facial pain [22]. It is
important to highlight that, although some studies show
that up to 100% of patients demonstrate pansinusitis on
tomography of the paranasal sinuses, 20% of these patients
did not present any of the symptoms listed, and 36% did
not present bilateral changes in the middle meatus [22].
One possible explanation for a low frequency of chronic
sinonasal complains would be a matter of priority, being
pulmonary and gastrointestinal problems prioritized by
patientsandfamily.Furthermore,an“adaptation”tochronic
nasal symptoms may occur [23].
Boari and Castro J´ unior [24] identiﬁed the following CF
symptoms whilst evaluating 34 CF patients from the city of
Sao Paulo: cough (88.2%), headache or facial pain (38.2%),
and nasal obstruction (29.1%). Rhinorrhea was reported by
only four patients. Franche and coworkers [25]i nP o r t o
Alegre, the southeast Brazilian’s capital in Rio Grande do
Sul state, found only two out of 23 patients with bilateral
polyposis and concerning nasal obstruction, nasal secretion,
and headache only eight (34.8%) reported nasal obstruction,
ten (43,5%) complained of nasal secretion, and none had
headache. Weber and Ferrari [26] (Botucatu, Sao Paulo
State)evaluated23patientswithanaverageageof6yearsand
4 months, and 22% of them complained of oral breathing.
3.Endoscopic Findings
There is a great variety of endoscopic ﬁndings in CF patients
and a trend toward increased incidence of diagnoses of nasal
polyps over time. From 1961 to 2005, the prevalence of nasal
polyposis varied from 5% to 57% [20, 24, 26–34]. This may
be explained by the increased survival rate of CF patients
in developed countries, by selection of patients, by size of
samples, by diﬀerences of age groups studied, and mainly
by the most recent routine use of nasal endoscopy as a
diagnostictechnique[1,19,20].BoariandCastroJ´ unior[24]
compared clinical, tomographic, and endoscopic ﬁndings
and veriﬁed that nasal endoscopy contributed enormously
to the evaluation of chronic rhinosinusitis and of nasal
polyposis in CF patients, reliably characterizing sinonasal
conditions.
Other studies carried out in Brazil have also shown
considerable variation in frequency of diagnosis of nasal
polyps in CF patients. Franco and colleagues [22]f o u n d
nasal polyps in only 14% of children and adolescents with
CF even using an evaluative technique similar to that used
in other studies published recently. Weber and Ferrari [26]
found nasal polyps in 39.1% of 23 CF patients aged one year
and nine months to 22 years and 8 months. Boari and Castro
J´ unior [24] found polyps in only three (8.82%) out of 34 CF
patients, from six to twenty-two years of age, evaluated using
nasalendoscopy.Francheandcoworkers[25]foundonlytwo
out of 23 patients with bilateral nasal polyps in both cases.
Sakano and colleagues [20] identiﬁed nasal polyps in 36%
of 50 patients, over two years of age, evaluated using rigid
endoscopy undergeneralanesthesia,a method that may have
allowed more accurate diagnosis of polyps, even small ones.
There is much genetic heterogeneity in CF, that is, a wide
range of mutations with a great variety of clinical presen-
tations. Thus the variation found in related nasal polyposis
may be explained by particular genotypic characteristics of
populations from a country that spans a continent. We
should also consider underdiagnosis of CF in Brazil and the
premature deaths of patients with pulmonary complications
and, maybe, those with associated nasal polyposis. In Brazil,
the survival of CF patients is lower than that in developed
countries where expectance of survival reaches 31.6 years. In
a Brazilian study conducted by Alvarez and colleagues [35],
themeanageofsurvivalfor104CFpatientsevaluatedwas18
years and four months after diagnosis.
Among 100 CF children and adolescents studied by
Franco and coworkers [22], patients with nasal polyps had
associated nasal secretions, identiﬁed using endoscopy, but
endoscopy did not identify the presence of nasal polyps and
symptoms such as cough, rhinorrhea, oral breathing, restless
sleep, headache, and nasal obstruction. In this study, there
was no statistically signiﬁcant association between nasal
polyps and patients’ age; however, 64.3% of patients with
polyps in this study by Franco et al. [22] were between four
and 12 years of age, which coincides with ages in the report
by Sakano and colleagues [20] (88.89% of cases of polyposis
in patients under 15 years of age). That is, among Brazilian
children with CF, the prevalence of polyps in younger
children is quite high. Nasal polyps have been identiﬁed inInternational Journal of Otolaryngology 3
Table 1: Symptoms, polyps, tomography and mutations in Brazilian CF patients.
City: Sao Paulo City
Estate: Sao Paulo
Boari and Castro
J´ unior [24]
City: Botucatu
Sao Paulo
Weber and Ferrari [26]
City: Campinas
Sao Paulo
Sakano and colleagues.
[20]
C i t y :B e l oH o r i z o n t e
Minas Gerais
Franco and
colleagues. [22]
City: Porto Alegre Rio
Grande do Sul
Franche and
colleagues. [25]
Symptoms
Cough (88.2%),
headache or facial pain
(38.2%)
22% of them
complained of oral
breathing
Cough (45%), oral
breathing (44%)
34.8% reported nasal
obstruction, ten
(43,5%) complained
of nasal secretion
Polyps 8.82% 39.1% 36% 14% 8.69
Tomography
(i)Lund-Mackay
average score of 13.3
(ii)considering criteria
for the endoscopic
diagnosis of chronic
rhinosinusitis: 93.54%
According to Johansson
and colleagues: grade I
in four patients
(44.4%), grade II in
one patient (11.1%),
and grade III in four
patients (44.4%)
Mucosal thickening in
50%, opaciﬁcation of
paranasal sinuses in 6%
and pseudomucocele in
40%
According to the
Lund-Kennedy score:
14 children with nasal
polyps had maximum
scores
Mutation in
ΔF508
O u to f2 3p a t i e n t s :
34% patients were
found with the genetic
mutation ΔF508/other,
13% ΔF508/ΔF508,
4% ΔF508/G542X,
4% G542X/other,
4% R1162X/R1162X,
and 39% patients
without speciﬁc
mutations
Out of the 50 patients:
38% ΔF508
heterozygotes,
32% ΔF508
homozygotes, other
mutations in 20%
a child as young as 8 months old; a diﬀerential diagnosis was
madeusingcomputedtomographyofthenoseandparanasal
sinuses [22].
Weber and Ferrari [26] did not ﬁnd any association of
gender, age, clinical severity, or genetic mutation with the
presence of nasal polyposis. The 14 children with nasal
polyps evaluated in the study conducted by Franco and
coworkers [22]hadmaximumscores,accordingtotheLund-
Kennedy scoring system, and polyposis obliterans were not
found. Weber and Ferrari [26] classiﬁed the polyposes ac-
cording to the scale by Johansson and colleagues [36]: grade
I in four patients (44.4%), grade II in one patient (11.1%),
and grade III in four patients (44.4%). Using endoscopy,
F r a n c h ea n dc o w o r k e r s[ 25] found other signiﬁcant endo-
scopic evidence in 23 CF patients. The inferior turbinate
was hypertrophic in 34.8%. In 22 out of the 46 nasal
cavities examined, the mucosa of the middle turbinate was
normal in 47.8%, pallid in 34.8%, and hyperemic in 17.3%.
Most patients (65.2%) had secretion in the nasal cavity:
serous (53.3%), mucoid (26.7%), and purulent (20%). The
relationship was statistically signiﬁcant between hyperemia
of mucosa of the middle turbinate and presence of nasal
discharge, with positive culture of aspirate from the middle
meatus (P = 0.0085 for hyperemic mucosa and P = 0.00272
for nasal discharge).
Sakano and coworkers [20], using endoscopy, found
secretion in the middle meatus in 54% of cases and medial
bulging of the lateral nasal wall in 58%. Franco and
colleagues [22] found medial bulging of the lateral nasal wall
in 41% (bilateral in 36% of them) and did not ﬁnd any
association between age and the presence of bulging. Boari
and Castro J´ unior [24] evaluated results of nasal endoscopy
according to the Lund-Kennedy scale [37] concerning the
distribution of mucosal edema, nasal secretions, and nasal
polyps and, considering criteria for the endoscopic diagnosis
of chronic rhinosinusitis, found that 73.52% had the disease
at the time of assessment.
4. Proﬁle of Cytokines in
SinonasalPolyposisinCF
Sinonasal polyposis in CF is classiﬁed as noneosinophilic
sinonasal polyposis, according to the histopathological ﬁnd-
ings. To better understand the pathogenic mechanisms of
nasal polyps in CF, several studies have tried to characterize
the inﬂammatory microenvironment, cytokines, adhesion
molecules, and ionic transport. A Brazilian study conducted
by Nunes and coworkers [38] analyzed the expression of
messenger ribonucleic acid (mRNA) for cytokines IL4, IL5,
IL6, IL8, GM-CSF, and INF-gamma in patients with CF,
who had nasal polyposis, and in a control group, using
reverse transcription-polymerase chain reaction (RT-PCR).
TheresultingexpressionofmRNAforIL5,IL6,IL8,andGM-
CSF was similar in the group with CF polyposis and in the
control group. Low values of INF-gamma and a tendency
to higher values of IL4 were associated with the CF group.4 International Journal of Otolaryngology
The reduction of INF-gama would be responsible for the
presence of bacteria or bacterial LPS (lipopolysaccharides)
in the intracellular medium. These bacteria stimulated
production of IL4 by Th2 cells. The results would reﬂect
intense inﬂammation with an increase in the eosinophilic
cationic protein, total IgE, intermediated by the increase of
IL4 and the low INF-gama [38].
5.Tomographic Findings
Computed tomography (CT) has become a valuable tool
for the diagnosis and monitoring of disorders of the upper
airwayinCFpatientsandisalsoessentialinplanningsurgical
cases, to study osseous structures. The main manifestations
are opaciﬁcation of paranasal sinuses, formation of muco-
celes/pseudomucoceles, agenesis or hypoplasia of the frontal
sinus, and medial bulging of the lateral nasal wall [39–43].
Virtually all paranasal sinuses were found radiologically to
be aﬀected in over 90% of patients over 8 months of age [2].
Boari and Castro J´ unior [24], using CT, evaluated 31
patients with CF, and found 93.54% presenting chronic rhi-
nosinusitis, as seen on radiologic studies. The Lund-Mackay
classiﬁcation of tomography staging [44] had an average
score of 13.3, varying from 1 to 24. The most aﬀected sinus
was the maxillary sinus, with 91.9% having opaciﬁcation
(45.1% complete opacity and 46.8% partial). In descending
order, there was a higher incidence of involvement of
the anterior ethmoid sinus (83.9%), frontal sinus (70%),
sphenoid (66.7%), and posterior ethmoid (54.8%). Despite
important changes on tomography, Boari and colleagues
believe that sinonasal disease shown by CT does not seem
to be directly related to surgical ﬁndings and that CT and
nasal endoscopic examination present a higher percentage
of positive correlation, while CT used with the medical
history presented the lowest correlation. The same authors
believe that based just on tomography there is probably an
overestimation of diagnosis of sinonasal disease.
Kobayashi and colleagues compared the Lund-Mackay
scores of tomography with various clinical aspects from
patients in a referral center in the south of Brazil (Rio
Grande do Sul) and found no statistical correlation [45].
They discussed that this score was not developed to analyze
these disease, but anyway show at the same time the need for
a speciﬁc tomography graduation system for CF patients and
that image alterations in these patients should be really care-
fully evaluated as symptomatic and asymptomatic patients
had similar results. Sakano and coworkers [20] examined
50 patients with CF using tomography and found absence
of changes in 4%, mucosal thickening in 50%, opaciﬁcation
of paranasal sinuses in 6%, and pseudomucocele in 40%.
No statistically signiﬁcant diﬀerences were found between
ﬁndings on tomography and diﬀerent genotypes or patient
status of health. In this study, there was an association
between the presence of medial bulging of the lateral nasal
wall identiﬁed using endoscopy and using CT, with 65.5% of
cases having pseudomucocele.
A condition described by Coste and colleagues [39],
pseudomucocele is made evident on CT scans speciﬁcally
in patients with CF. Published reports show controversy
concerning terminology for this pathological entity of the
sinuses, more studied since routine tomographic examina-
tionsbecamepartoftheevaluationofpatientswithCF.Some
authorsusetheterm“mucocele”andothers“mucopiosinusi-
tis.” Most often the more accurate term is “pseudomucocele”
sincethereisviscoussecretionintheparanasalsinuses,deter-
mining CT images of central hyperdensity and peripheral
hypodensity. It is not a true epithelially walled cystic lesion
but rather secretion surrounded by inﬂammatory tissue
which follows the shape of the walls of the sinuses, with a
tendency to expand [39].
Portes and colleagues [46]( S a oP a u l o )r e p o r t e dac a s e
of a child two years and one month old with chronic nasal
obstruction since birth; CT showed opaciﬁcation of the
maxillary and ethmoid sinuses bilaterally and the formation
of a cystic appearance with a halo of peripheral enhancement
around the maxillary sinuses. These cystic formations, pseu-
domucoceles, led to protrusion of the lateral nasal wall and
narrowing of the nasal cavity. Pseudomucocele, therefore,
may be considered a frequent manifestation found in studies
of series of nasal manifestations in CF patients.
Thom´ ea n dc o w o r k e r s[ 47] reported a case of a 10-
month-old child with nasal obstruction, ethmoide tomo-
graphic ﬁndings compatible with mucocele and CF was
conﬁrmed by the sweat test [47]. Diagnosis of mucoceles is
commonly established using computed tomography (CT) of
paranasal sinuses, which shows osseous erosion of the walls
of paranasal sinuses, with smooth outward displacement.
Upon magnetic resonance (MRI), mucoceles will show vari-
able signal intensities in both T1-and T2-weighted images. A
disadvantage of MRI when compared with CT is the absence
of osseous details; therefore MRI has no value in surgical
planning. In pediatric patients with CF and suspected
mucocele, MRI is essential to help eliminate other entities
suchasmeningocele,rhabdomyosarcoma,hemangioma,and
neuroblastoma [48].
6.Microbiology
Only two Brazilian studies involving CF patients evaluated
upper airways from a microbiological point of view. Franche
et al. [25], from Porto Alegre (Rio Grande do Sul State),
analyzedthebacteriologyofaspiratefromthemiddlemeatus
and sputum of 23 patients with CF. The Junh-Tym-Tap
aspiration system and a rigid endoscope were used to collect
material. There was a total of 42 aspirations. In seventeen
(73.91%) out of 23 patients, cultures were negative; in six
they were positive (26.08%). Out of 42 aspirations, 73.81%
were negative, and 26.19% (11 aspirates) were positive.
Out of 11 positive aspirations two showed Pseudomonas
aeruginosa (both from the same patient), three showed
Staphylococosaureus,twoHaemophylusinﬂuenzae,twoStrep-
tococcuspenumoniae,andtwoAcinetobacter lwoﬃ.Samplesof
sputum from all patients presented bacterial growth, 36.43%
with growth of two germs, the growth of Pseudomonas
aeruginosa in 40%. Other bacteria found in the sputum
were mucoid Pseudomonas aeruginosa (20%), Staphylococcus
aureus (23.33%), Haemophilus inﬂuenzae (6.68%), Serra-
tia marcescens (3.33%), Acinetobacter lwoﬃ (3.33%), andInternational Journal of Otolaryngology 5
Streptococcus pneumoniae (3.33%). No association was ob-
served between the results of sputum cultures and results for
aspirate from the middle meatus [24].
Sakano and coworkers [20], from Campinas (Sao Paulo
State), collected samples using a swab of the oropharynx,
secretions gathered by maxillary antrostomy, and secretions
gathered using endotracheal tubes, representing tracheal
secretions from 50 CF patients. The distribution of results
of cultures from diﬀerent sites (maxillary sinus, trachea, and
oropharynx) was as seen in Table 1. The incidence of colo-
nization by Pseudomonas aeruginosa and S. aureus was 53%
and80%,respectively.SimultaneousﬁndingsofP. aeruginosa
in three sites investigated in children and adolescents who
were evaluated are directly related to pathophysiology of
chronic colonization of CF patients by this bacterium and
suggest a high level of early contamination of the airways.
7.Genetics
The gene for CF is located in chromosome 7, at locus q31,
formed by 250 kilobases of DNA, with 27 exons. It encodes
an mRNA of 6.5 kilobases that transcribes a transmembrane
regulator protein for ionic transport, comprising 1480
amino acids, known as CFTR (cystic ﬁbrosis transmembrane
conductance regulator). The CFTR protein is essential for
ionic transport through cellular membranes, being involved
in regulating the ﬂow of Cl, Na, and water [15–17].
One of the most important aspects of the current
approach to CF is the great heterogeneity of the disease
regarding its presentation, clinical course, and prognosis.
Since the gene for CF was discovered, many hundreds of
mutations have already been identiﬁed. The most frequent
mutationinCaucasiansisΔF508,deletionofthreebasepairs,
causing the loss of an amino acid (phenylalanine) at the 508
position of the CFTR protein, which prevents its appropriate
functioning. In Brazil, the prevalence of mutation in ΔF508
varies according to the population studied. It is present in
27% to 52% of chromosomes: Martins and coworkers [49]
found 33% in Sao Paulo and Raskin and colleagues [50]
found 49% in Rio Grande do Sul, 27% in Santa Catarina,
and52%inSaoPaulo.Alvarezandcoworkers[35]genotyped
92.31% of 104 patients studied in Campinas, and the ΔF508
mutationwaspresentin50%of192chromosomesstudied.A
lower prevalence of this mutation is expected in populations
withgreatethnicdiversity.OthermutationsfoundbyAlvarez
and colleagues were G542X (4.17%), N1303K (2.08%),
G551D (1.04%), R553X (0.52%), and W1282X (0.52%).
Weber and Ferrari [26] investigated genetic mutations
of 23 patients studied, and eight patients were found with
the genetic mutation ΔF508/other, three ΔF508/ΔF508, one
ΔF508/G542X, one G542X/other, one R1162X/R1162X, and
nine patients without speciﬁc mutations. In this study,
no association was found between the genotype and the
presence or severity of nasal polyposis [25].
The study conducted by Sakano and coworkers [20]
researched the most frequent mutations in Brazil, dividing
into three groups: ΔF508/ΔF508 (homozygotes), ΔF508 het-
erozygotes, and other mutations. Out of the 50 patients eval-
uated, results were 38% ΔF508 heterozygotes, 32% ΔF508
homozygotes, other mutations in 20%, and 10% were
not evaluated. No association was observed between the
severity of the disease and the genotype investigated. An
association was observed between CF genotype with the
presence of nasal polyposis (P = 0.006), but no association
was observed among genotype and gender, age, secretion
in middle meatus, or medial bulging of the lateral nasal
wall. The patients with the ΔF508 heterozygote had more
abnormalitiesseenonCTthandidthehomozygoticpatients,
but there was no statistically signiﬁcant diﬀerence. Sakano’s
group believes the absence of an association of the genotype
with several of the variables studied is due to the small size of
the sample.
8.Otological Findings
Martins and coworkers [51], from Belo Horizonte (Minas
Gerais State), evaluated 120 clinically stable patients with CF.
Of these, 57% had had no otitis media in the past, 65% had
had no otitis in the ﬁrst year of life, and 71% had had no
otitis in the year before being included in the study. One
hundred and thirteen patients (94%) had normal otoscopy;
only3%hadalterationsindicatingotitismediawitheﬀusion.
Tympanometry showed a type A tympanogram in 91%.
The sensorineural hearing loss (SNHL) in CF patients
may be caused by ototoxic drugs such as aminoglycosides,
commonlyindicatedforthetreatmentofpulmonarydiseases
in CF patients. Piltcher and colleagues [52], from Porto
Alegre (Rio Grande do Sul), conducted a retrospective study
involving 107 medical charts of children with CF, with an
average age of 7.87 years (SD 4.49). Audiological tests were
carried out in only 39.3% of these children, and 28% were
diagnosedwithsensorineuralhearinglossofvaryingdegrees.
Thestapedialreﬂexwasabsentin36%ofcases.Tympanome-
try showed a curve A in 91%. All patients received a variable
amount of aminoglycosides courses. The study was unable
to correlate the amount of this antibiotics and or severity
of disease with the prevalence of hearing loss. The frequent
use of aminoglycosides and the relatively high prevalence
of sensorineural hypoacusia reinforce the importance of an
audiological evaluation of patients with CF to improve the
quality of life and survival of this population in Brazil.
Unpublished data from this same center (Weigert et al.)
indicates that ultrafrequency audiometry would show even
higherprevalenceofearlyhearinglossdetectionamongthese
patients.
9. Conclusion
There has been increasing amount of data on CF patients
around the world. Brazil followed this same tendency of sci-
entiﬁcpublications.WhatmakesBrazil’sdataveryimportant
is its unique continental geographical characteristics and
population with a colonization history that leads to a great
amount of mixigenation between European and Native
American ancestors. If those facts interfere with the clinical
presentation of this genetic common disease is not known
y e t .T h el o w e rs u r v i v a lr a t e sc o m p a r e dt od e v e l o p e dc o u n -
tries do not seem to be directly related to those genetic6 International Journal of Otolaryngology
diﬀerences, but raise the possible existence of mutations not
yet known that lead to undiagnosed patients. On the other
hand it is clear that the actual state of medicine practice
for those patients has been improving and this results
from recognition by Brazilian physicians for the need to
followinternationaltendencyandestablishmultidisciplinary
centerstofollowandcontrolthesepatients.Asaconsequence
there will be an increasing amount of research and data
to be shared. The best performance is also conﬁrmed
in improving survival rates, despite the need to continue
to seek medical awareness about the importance of early
diagnosis. The Brazilian experience conﬁrms, as do reports
fromothercountries,thatanotolaryngologistshouldbepart
of an interdisciplinary team, with an important role in the
diagnosisandappropriatemanagementofdirectandindirect
manifestations of this disease. Hearing must be followed
closely due to systemic intravenous antibiotics. As in other
countries sinus alterations must be also better understood as
most patients have it, but few present symptoms. The upper
respiratory phenotypic manifestations among Brazilians do
not seem to be really diﬀerent from other populations. It
also brings up to discussion the need to study rhinosinusitis
among these patients as a diﬀerent entity. When it should be
considered a disease and how to treat it remain a basic issue.
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